Evidence-Based Treatment Options in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck
about
Advances in T-cell checkpoint immunotherapy for head and neck squamous cell carcinoma.A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.New developments in the management of head and neck cancer – impact of pembrolizumab.Novel Therapeutic Targets in Cutaneous Squamous Cell Carcinoma.Invasion-Related Factors as Potential Diagnostic and Therapeutic Targets in Oral Squamous Cell Carcinoma-A Review.Anti PD-L1 DUrvalumab combined with Cetuximab and RadiOtherapy in locally advanced squamous cell carcinoma of the head and neck: A phase I/II study (DUCRO).Effects of Cetuximab and Erlotinib on the behaviour of cancer stem cells in head and neck squamous cell carcinoma.Preclinical Development of Oncolytic Immunovirotherapy for Treatment of HPVPOS Cancers.Patients' experience of recurrent/metastatic head and neck squamous cell carcinoma and their perspective on the EORTC QLQ-C30 and QLQ-H&N35 questionnaires: a qualitative studyThe role of biosimilars in value-based oncology careA neoepitope derived from a novel human germline APC gene mutation in familial adenomatous polyposis shows selective immunogenicityActivation of immune responses in patients with relapsed-metastatic head and neck cancer (CONFRONT phase I-II trial): Multimodality immunotherapy with avelumab, short-course radiotherapy, and cyclophosphamide
P2860
Q47097238-9D74BDEC-5722-45E8-9062-B80E85B8C6BCQ49821268-772FF868-8AF4-4646-9C35-D91C2B427679Q50336126-14B9E661-3693-4A91-9505-440BBC25C1D2Q52599427-89FF5715-60B7-4D8B-A703-3FE6D8EBD292Q54957173-A56C9FBB-DDD2-49C7-896F-7B1F5B4A4DC7Q54982410-E827DDCB-F704-41DD-9312-E9EA402AF93FQ55296915-FA4EDE23-BDD0-4E8C-B695-06E082EA6E51Q55652233-92C30E93-9EBD-4D8B-8D0B-0DA260AFCDA1Q56524811-26F68F83-4ADD-4F90-8EF4-A5F50E253F89Q58605622-263FF5AC-9D24-47BD-A7DA-44812A906B61Q58696044-AC1149B7-57B7-4FE0-BF03-1311F48651EFQ58785196-EDD39DB9-89DF-4A08-B1BC-0F197AA54888
P2860
Evidence-Based Treatment Options in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck
description
2017 nî lūn-bûn
@nan
2017 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Evidence-Based Treatment Optio ...... Carcinoma of the Head and Neck
@ast
Evidence-Based Treatment Optio ...... Carcinoma of the Head and Neck
@en
type
label
Evidence-Based Treatment Optio ...... Carcinoma of the Head and Neck
@ast
Evidence-Based Treatment Optio ...... Carcinoma of the Head and Neck
@en
prefLabel
Evidence-Based Treatment Optio ...... Carcinoma of the Head and Neck
@ast
Evidence-Based Treatment Optio ...... Carcinoma of the Head and Neck
@en
P2093
P2860
P356
P1476
Evidence-Based Treatment Optio ...... Carcinoma of the Head and Neck
@en
P2093
Ana Ferreira Castro
Athanassios Argiris
Jeltje Schulten
Kevin J Harrington
Lisa Licitra
Makoto Tahara
Pauline Chomette
P2860
P356
10.3389/FONC.2017.00072
P577
2017-05-09T00:00:00Z